Bethesda, United States
Northpond Ventures is a multi-billion-dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has consistently been named one of the most active lead life science investors in venture industry rankings. It is deeply engaged in the academic ecosystem, having founded The Laboratory for Bioengineering Research and Innovation at the Wyss Institute at Harvard University; launched the MIT-Northpond Program – Advancing Life Science & Engineering Innovation; launched the Northpond Laboratories — Program for Research and Innovation at Stanford Medicine; and sponsored a prize for women entrepreneurs at MIT. It has led or co-led over 60 financings over the past several years and sits on the board of the vast majority of these businesses. Learn more at npv.vc.
92
Total Investments
55
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Finance +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Northpond Ventures
Recent Investments (92)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series E | •••••• | Jan 2026 | |
| Series C | •••••• | Dec 2025 | |
| Series A | •••••• | May 2025 | |
| Early VC | •••••• | May 2025 | |
| Series D | •••••• | Apr 2024 | |
•••• ••••
|
Venture Round | •••••• | Feb 2024 |
|
•••• ••••
|
Series C | •••••• | Jan 2024 |
|
•••• ••••
|
Series C | •••••• | Nov 2023 |
|
•••• ••••
|
Series B | •••••• | Nov 2023 |
|
•••• ••••
|
Series B | •••••• | Aug 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
